Results 161 to 170 of about 6,666,035 (292)

European Society for Medical Oncology (ESMO) congress 2025. [PDF]

Lancet Reg Health Eur
Nedic I.
europepmc   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source

Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. [PDF]

Curr Oncol
Kajiura S, Satake H, Hayashi R, Yoshino T.   +3 more
europepmc   +1 more source

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

Molecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad, Silvio Carlo Ermanno Tosatto, Emanuela Leonardi   +2 more
wiley   +1 more source

Nutritional Risk in Patients Admitted to Medical Oncology Departments: Prevalence, Associated Factors and Clinical Outcomes in a Multicentre Prospective Study. [PDF]

Nutrients
Teigell Muñoz FJ, Llobera Rius L, Medina Ortega L, Villacé Gallego P, Marco-Hernández J, Fernández Fernández EP, Esquerrà Molas A, Liesa Delgado L, Sáez Urán LM, González Olmedo J, Heredia-Mena C, Romero Hernández J, Llaberia-Torrelles M, Delgado Heredia MJ, Bazaga Rodas N, Fernández-Cordón L, Macía-Rodríguez C, Soldado J, García-Villa A.   +18 more
europepmc   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Medical College, 1952

, 1952
This glass lantern slide features a black and white photograph of the Medical College of South Carolina in ...
Medical College of South Carolina (1952-1969). Department of Medical Illustration
core  

Radiation and Medical Oncology Perspectives on Oligometastatic Disease Treatment. [PDF]

Fed Pract
Wallach JB, Malhotra S, Lee SP, Hoffman-Hogg L, Shapiro R, Wechsler G, Faricy-Anderson K, McGunigal MC, Kelly MD, Gutt R.   +9 more
europepmc   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

Association of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) Scores with Guideline Recommendations in Breast Cancer. [PDF]

Curr Oncol
Salman B, Yehia I, Al Sharqi H, Al Shidi R, Al Dhahri MA, Al Ghefeili S, Makhloufi M, Al Ajmi A, Al Farsi S, Al Kiyumi Z, Al Ishaq ZRR, Ayaad OA, Al Baimani K.   +12 more
europepmc   +1 more source